Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118270 · ClinicalTrials.gov registry record · NA
Shared Decision-Making: AFib 2gether Mobile App
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04118270 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 50 participants.
The verdict
NCT04118270, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patients can determine their risk of stroke due to atrial fibrillation and prioritize questions and concerns for discussion with their cardiology provider.
Interventions
- DEVICE Afib 2gether TM Mobile Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2020-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04118270
The ClinicalTrials.gov registry entry for NCT04118270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Afib 2gether TM Mobile Application is the first listed.
NCT04118270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04118270 about?
NCT04118270 is a clinical study titled "Shared Decision-Making: AFib 2gether Mobile App". Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patients can determine their risk of stroke due to atrial fibrillation and prioritize questions and conce...
What is the current status of trial NCT04118270?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-11-01. Estimated completion is 2020-06-26.
What interventions are being tested in trial NCT04118270?
The interventions under investigation include: Afib 2gether TM Mobile Application (DEVICE).
Who is sponsoring clinical trial NCT04118270?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.